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OBJECTIVE: To evaluate the association between tourniquet and total operative time during total knee arthroplasty
and the occurrence of deep vein thrombosis.
METHODS: Seventy-eight consecutive patients from our institution underwent cemented total knee arthroplasty for
degenerative knee disorders. The pneumatic tourniquet time and total operative time were recorded in minutes.
Four categories were established for total tourniquet time: ,60, 61 to 90, 91 to 120, and .120 minutes. Three
categories were defined for operative time: ,120, 121 to 150, and .150 minutes. Between 7 and 12 days after
surgery, the patients underwent ascending venography to evaluate the presence of distal or proximal deep vein
thrombosis. We evaluated the association between the tourniquet time and total operative time and the occurrence
of deep vein thrombosis after total knee arthroplasty.
RESULTS: In total, 33 cases (42.3%) were positive for deep vein thrombosis; 13 (16.7%) cases involved the proximal
type. We found no statistically significant difference in tourniquet time or operative time between patients with or
without deep vein thrombosis. We did observe a higher frequency of proximal deep vein thrombosis in patients
who underwent surgery lasting longer than 120 minutes. The mean total operative time was also higher in patients
with proximal deep vein thrombosis. The tourniquet time did not significantly differ in these patients.
CONCLUSION: We concluded that surgery lasting longer than 120 minutes increases the risk of proximal deep vein
thrombosis.
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INTRODUCTION
The induction of deep vein thrombosis (DVT) following
total knee arthroplasties (TKAs) and total hip arthroplasties
is frequently studied (1), although DVT also results from
other knee procedures (2). Despite the importance of and
interest in this problem, most researchers studying DVT
generally focus on postoperative prophylaxis. Surprisingly,
few studies have investigated the isolated risk factors for
DVT associated with TKA. Although controversy exists
regarding the role of TKA alone as a risk factor for DVT (3–
7), some researchers believe that bone manipulation, ream-
ing of the medullary canal, and the operative time are
relevant risk factors for DVT (8,9). Another important and
controversial factor related to TKA is the use of surgical
tourniquets. Although all of these factors are mentioned in
the literature, operative time has received little attention as
an isolated risk factor for DVT in TKA.
We used ascending venography (AV) to determine the
presence of proximal and distal DVT after TKA and
evaluated the association between tourniquet time and
TKA operative time and the occurrence of DVT.
PATIENTS AND METHODS
Seventy-eight consecutive patients from our institution
underwent cemented TKA for degenerative knee disorders.
Of the 78 patients, 78.2% were women and 21.8% were men,
with an average age of 65.1 years (range, 31–88 years; SD,
11.5 years). Osteoarthrosis was the diagnosis in 74.4% of the
cases, rheumatoid arthritis in 21.8%, and other disorders in
the remaining 3.8%.
All total knee arthroplasties were performed with the
same technique. An intramedullary guide was used for
distal femoral osteotomy. An extramedullary guide was
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used for proximal tibial osteotomy. We recorded the total
pneumatic tourniquet time and total operative time in
minutes. In all cases, the use of a tourniquet was interrupted
for hemostasis after the implant was cemented and before
wound closure. Four categories were established for total
tourniquet time: ,60, 61 to 90, 91 to 120, and .120 minutes.
The total operative time was consistently defined as the time
from the initial incision to the last suture stitch made to
close the incision. Three categories were defined for
operative time: ,120, 121 to 150, and .150 minutes. Only
two patients (3.1%) were administered a general anesthetic;
all other patients received a spinal block. All patients
received DVT prophylaxis with oral anticoagulants for 12
days, with an international normalized ratio maintained at
approximately 2.5 (range, 2.0–3.0) in all cases (10).
An ascending venography, for which the patients
provided informed consent, was performed between 7 and
12 days after surgery after discharge from the hospital. The
study end point was defined based on the execution of
bilateral AV. The AV was performed by a specialist in
vascular radiology. The technique applied was performed
essentially as described by Rabinov and Paulin (11). The
presence of clinically manifested DVT and/or pulmonary
embolism was also considered. The clinical manifestations
of DVT were defined as follows: greater edema of the
affected lower limb than would be expected for the
procedure, intense pain on palpation of the calf, and pain
on passive dorsiflexion of the foot. An AV finding that was
considered to be positive for DVT was the presence of blood
clots in the vein lumens (Figure 1). DVTs were characterized
as occurring on the operated side, on the contralateral side
or bilaterally and were classified as proximal or distal DVT.
We used the chi-squared test for the comparison of
qualitative variables between groups. For the quantitative
variables, we used Levene’s test to determine the homo-
geneity of variances and the Kolmogorov-Smirnov test to
determine the normality of the distribution. In cases in
which both conditions were met, the averages of both
groups were compared using Student’s t-test. A level of
significance of 5% was adopted in the analyses. The
statistical program used was SPSS (SPSS for Windows,
release 6.0, SPSS Inc., Chicago, IL, USA).
RESULTS
We found that 45 patients (57.7%) had negative bilateral
AV, and 33 (42.3%) had DVT. Thirteen patients (16.7%) had
a proximal DVT. We compared the patients with DVT with
those without DVT. We also compared the cases with
proximal DVT with the cases involving distal DVT and the
cases with normal findings on AV.
The baseline characteristics of our patients are summar-
ized in Table 1. We observed that patients with DVT were
older than patients without DVT (62.9¡12.3 vs 68.2¡9.7
years, respectively; p= 0.04). When we compared only the
patients with proximal DVT with the other patients, we
found no difference in age between the groups (64.3¡12.0
vs 69.2¡7.8 years, respectively; p= 0.2). We also observed
that osteoarthritis was the most frequent diagnosis and was
found in almost 90% of patients with DVT.
The total population did not demonstrate any statically
significant differences in tourniquet or total operative time
based on the presence or absence of DVT, as shown in
Table 2. Considering only patients with proximal DVT, we
found no significant difference in tourniquet time (p= 0.08).
For total operative time, we observed a significant difference
between the groups, with a higher frequency of proximal
DVT in patients with an operative time that was longer than
120 minutes (p= 0.05) (Table 3). Patients with proximal DVT
also had a higher mean operative time (146.9¡20.4 vs
127.9¡22.4 min, respectively; p= 0.01) (Table 4).
DISCUSSION
The systematic reviews of DVT in TKA almost exclusively
address therapeutic alternatives for this condition (12–15);
few reviews address the risk factors. We believe that
undergoing TKA is itself a risk factor for DVT (3–
5,12,16,17). One of the few reports that contradict this
hypothesis is a report by Fowkes et al. (18), which addresses
the general aspects of the incidence of DVT, reporting it as
approximately 10,000 persons/year in the general popula-
tion. Bhandari et al. (19) warned that the inherent limitations
of those studies and the lack of attention to other risk factors
render these reports of limited value. Gross et al. (20) noted
that studies on DVT prophylaxis have demonstrated a low
incidence of DVT complications after total hip arthroplasty
and TKA, which is far below the incidences that were initially
reported in venography studies conducted to detect asymp-
tomatic DVT. Improving the techniques used in perioperative
orthopedic care should reduce thromboembolic complica-
tions, regardless of prophylaxis. According to Bergqvist et al.
Figure 1 - An ascending venogram of a patient after total knee
arthroplasty showing deep vein thrombosis (arrows) in the lower
limb.
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(1), the incidence of DVT is higher after TKA than after total
hip arthroplasty.
Although many authors accept the possibility of DVT
with these procedures, others no longer consider this
complication to be a serious problem (21,22). Some authors
believe that mechanical prophylaxis, even with limited
resources, is adequate in all cases of TKA (23–25), whereas
others believe that pharmacologic prophylaxis in arthro-
plasty is indicated in select cases according to the individual
risk for DVT (26). We agree with the view of Haas et al. (14);
although there is no ideal prophylaxis, a multimodal
approach that combines pharmacologic therapy with
mechanical prophylaxis has proven to be safe and effective.
The number of studies that clearly define the risk factors
for DVT in TKA remains small. Surgical and orthopedic
aspects, such as the duration of tourniquet use and
operative time, are not identified as risk factors by some
authors (6,7).
The frequency of DVT observed in TKA varies from 20.3%
to 84%, regardless of prophylaxis. In the proximal form of
DVT, these values range from 4.4% to 20% (6,27–30). In our
study, we observed only one case of clinical DVT, which
made statistical analysis unfeasible. Although most studies
report small numbers of patients with symptomatic DVT,
Wang et al. (28) observed this clinical phenomenon in up to
70% of cases. There were no cases of pulmonary embolism
in the present study. The frequency of pulmonary embolism
has been reported to be low, varying between 0 and 20%
(31,32), but most studies have reported that the frequency is
approximately 1% (6,33,34). In our analyses, we only
considered cases of general DVT and proximal DVT, which
were specifically studied because these forms are consid-
ered to potentially have more severe complications
(30,35,36).
Data related to the surgical procedure itself are always
important to orthopedists. The most optimal moment at
which the surgical technique can be evaluated and modified
for the patient’s benefit is during the operation. The type of
anesthesia used is certainly one of the most frequently
evaluated topics in the literature, although some doubts
remain regarding the effects of anesthesia type on DVT
incidence. Researchers have studied epidural block alone
versus general anesthesia, and most data suggest that
epidural block should be protective against DVT (29,37–
40). However, in a recent article, Macfarlane et al. (41)
questioned these results. Evaluating anesthesia in isolation
was not the objective of our study. The high frequency of
spinal blocks in the present study (96.9%) can be attributed
to the routines of the anesthesia service. Thus, it was not
possible to detect the influence of the type of anesthesia on
the occurrence of DVT.
Table 1 - Patient baseline characteristics.
Population Without DVT With DVT p-value
Gender
no. (%) Male 17 (21.8) 11 (24.4) 6 (18.2) 0.51
Female 61 (78.2) 34 (75.6) 27 (81.8)
Age Mean (range) 65.1 (31-88) 62.9 (31-88) 68.2(39-82) 0.04*
Ethnic group
no. (%) White 56 (71.8) 30 (66.7) 26 (78.8)
Black 14 (17.9) 11 (24.4) 3 (9.1) 0.21
Other 8 (10.3) 4 (8.9) 4 (12.1)
Diagnosis
no. (%) Osteoarthritis 58 (74.4) 29 (64.4) 29 (87.9)
Rheumatoid arthritis 17 (21.8) 14 (31.1) 3 (9.1) 0.05*
Other 3 (3.8) 2 (4.4) 1 (3.0)
BMI Mean (range) 29.2 (18.5-48.3) 29.2 (18.5-41.4) 29.3 (21-48.3) 0.95
*significant p-value.
BMI - body mass index.
Table 2 - The population distribution based on
tourniquet (n =74) and operative times (n= 78) and a
comparative analysis of patients with and without DVT.
Variable No. of Patients (%) p-value
Population Without DVT With DVT
Tourniquet time
(min)
,60 6 (8.1) 3 (7.0) 3 (9.7) 0.19
61–90 33 (44.6) 21 (48.8) 12 (38.7)
91–120 32 (43.2) 19 (44.2) 13 (41.9)
121–150 3 (4.1) — 3 (9.7)
Surgery time (min)
,120 24 (31.1) 16 (35.6) 8 (24.2) 0.56
121–150 43 (53.8) 23 (51.1) 20 (60.6)
.150 11 (14.1) 6 (13.3) 5 (15.2)
Chi-squared test.
DVT, deep vein thrombosis.
Table 3 - The population distribution by tourniquet
(n= 74) and operative times (n= 78) and a comparative
analysis of patients with and without proximal DVT.
Variable No. of Patients (%) p-value
Without
Proximal DVT
With Proximal
DVT
Tourniquet time (min)
,60 5 (8.1) 1 (8.3) 0.08
61–90 27 (43.5) 6 (50.0)
91–120 29 (46.8) 3 (25.0)
121–150 1 (1.6) 2 (16.7)
Surgery time (min)
,120 23 (35.4) 1 (7.7) 0.05*
121–150 35 (53.8) 8 (61.5)
.150 7 (10.8) 4 (30.8)
Chi-squared test; *significant value.
DVT, deep vein thrombosis.
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Wilson et al. (42) stated that traction of blood vessels,
which are more constricted closer to the bone as a result of
the tourniquet, increases the likelihood of blood vessel
lesions. Wauke et al. (43) postulated that the use of
tourniquets may be associated with the occurrence of
DVT, although they did not present any concrete data to
support this theory. In evaluating our data, we did not
observe any significant results regarding the overall
presence of DVT in relation to a longer tourniquet time.
In our analysis of patients with proximal DVT, we
observed a higher likelihood of DVT with longer tourniquet
times, but this association was not statistically significant
(p=0.08). This observation lends some support to the
findings of Abdel-Salam and Eyres (48), who reported a
greater number of patients with proximal DVT when
tourniquets were used.
Total operative time was considered to be significantly
associated with the incidence of proximal DVTs, which as
mentioned earlier, are considered to be the more severe
DVT type (30,35,36). A report by Stringer et al. (2) was the
only report we found indicating that the total operative time
is a risk factor, although it did not define the cutoff point for
operative time. Our data enabled us to conclude that a total
operative time of .2 hours is correlated with a higher
frequency of proximal DVT. The results of the analysis of
these variables when considered as continuous categories
for total operative time generated a p-value of 0.01, which
further reinforces our findings.
Although this study has provided some interesting
findings, it also has some limitations. We performed a
case-control study, an observational study in which patients
were selected on the basis of whether they have the disorder
under study, in this case, DVT. Because this type of study
does not involve direct experimentation or variable manip-
ulation, the validity of the statistical association between
exposure and disease must be made under conditions that
are not strictly controlled (49). Therefore, a priori power
analysis and sample size determination were not per-
formed. We observed differences between the groups
concerning age and diagnosis. Patients with DVT were
older than patients without DVT. This observation lends
some support to the findings of Markovic-Denic et al. (50),
who reported that age is a significant risk factor for DVT.
Considering only patients with proximal DVT, we found no
difference between the groups. We believe that, for this
subgroup of patients, a longer operative time is an
important risk factor for DVT.
Despite our conviction concerning the link between
operative time and DVT, which was confirmed by our
findings, we do not recommended rushing the surgical
procedure in an attempt to shorten it because other equally
severe problems, such as poor component alignment, poor
ligament balance, and unsatisfactory homeostasis, may
develop. We believe that the most effective way to shorten
surgery is detailed planning, discipline, and familiarization
of the surgical team with the surgical instruments. We
should note that our institution is a training center for large
numbers of medical residents, who perform many TKAs.
We conclude that a total operative time of .120 minutes,
which is generally sufficient for a careful procedure in the
majority of TKAs, increases the risk of proximal DVT, and
although our findings were not statistically significant, a
tourniquet time of .90 minutes should be considered as a
possible risk factor for proximal DVT.
AUTHOR CONTRIBUTIONS
Hernandez AJ was the main author and researcher and performed patient
and data evaluation, the statistical analyses, and manuscript writing.
Almeida AM and Favaro E were involved in data analysis and manuscript
writing. Sguizzato GT performed patient evaluations and collected data.
REFERENCES
1. Bergqvist D, Bergentz SE, Fredin H. Thromboembolism in orthopaedic
surgery. Acta Orthop Scand. 1984;55(3):247-50.
2. Stringer MD, Steadman CA, Hedges AR, Thomas EM, Morley TR,
Kakkar VV. Deep vein thrombosis after elective knee surgery. An
incidence study in 312 patients. J Bone Joint Surg Br. 1989;71(3):492-7.
3. Caprini JA, Arcelus JI, Reyna JJ. Effective risk stratification of surgical
and nonsurgical patients for venous thromboembolic disease. Semin
Hematol. 2001;38(2 Suppl 5):12-9.
4. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr
et al. Prevention of venous thromboembolism. Chest. 2001;119(1
Suppl):132S-5S.
5. Haas S. Prevention of venous thromboembolism: recommendations
based on the International Consensus and the American College of Chest
Physicians Sixth Consensus Conference on Antithrombotic Therapy. Clin
Appl Thromb Hemost. 2001;7:171-7, http://dx.doi.org/10.1177/10760
2960100700301.
6. Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep-vein thrombosis
following total knee replacement. An analysis of six hundred and thirty-
eight arthroplasties. J Bone Joint Surg Am. 1984;66(2):194-201.
7. Kim YH, Kim VE. Factors leading to low incidence of deep vein
thrombosis after cementless and cemented total knee arthroplasty. Clin
Orthop Relat Res. 1991;(273):119-24.
8. Haas S. Managing the risk of venous thromboembolism in orthopedics:
concluding remarks. Orthopedics. 1997;20(Suppl):26-7.
9. Zaw HM, Osborne IC, Pettit PN, Cohen AT. Risk factors for venous
thromboembolism in orthopedic surgery. IsrMedAssoc J. 2002;4(11):1040-
2.
10. Geerts W, Heit J, Clagett J, et al. Prevention of venous thromboembolism.
Chest. 2001;119:(Suppl 1):132S-175S.
11. Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg.
Arch Surg. 1972;104(2):134-44, http://dx.doi.org/10.1001/archsurg.1972.
04180020014004.
12. Brookenthal KR, Freedman KB, Lotke PA, Fitzgerald RH, Lonner JH. A
meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
J Arthroplasty. 2001;16(3):293-300, http://dx.doi.org/10.1054/arth.2001.
21499.
13. Pellegrini VD Jr, Sharrock NE, Paiement GD, Morris R, Warwick DJ.
Venous thromboembolic disease after total hip and knee arthroplasty:
current perspectives in a regulated environment. Instr Course Lect.
2008;57:637-61.
14. Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J,
Pellegrini V, et al. Prevention of symptomatic pulmonary embolism in
patients undergoing total hip or knee arthroplasty. J Am Acad Orthop
Surg. 2009;17(3):183-96.
15. Haas SB, Barrack RL, Westrich G. Venous thromboembolic disease after
total hip and knee arthroplasty. Instr Course Lect. 2009;58:781-93.
16. Westrich GH, Haas SB, Mosca P, Peterson M. Meta-analysis of
thromboembolic prophylaxis after total knee arthroplasty. J Bone Joint
Surg Br. 2000;82(6):795-800, http://dx.doi.org/10.1302/0301-620X.82B6.
9869.
Table 4 - Analysis of patients with proximal DVT and
patients without proximal DVT by tourniquet (n =74) and
operative times (n= 78) and a comparison of means.
Variable No. of Patients (%) p-value
Without
Proximal DVT
With
Proximal DVT
Tourniquet time (min)
m¡SD 88.7¡18.5 94.9¡22.6 0.31
Range 45–125 44–130
Surgery time (min)
m¡SD 127.9¡22.4 146.9¡20.4 0.01*
Range 60–195 120–200
Chi-squared test, *significant value.
DVT, deep vein thrombosis; m, mean; SD, standard deviation.
Tourniquet, Surgery Duration, and DVT in TKA
Hernandez AJ et al.
CLINICS 2012;67(9):1053-1057
1056
17. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis
against venous thromboembolism after total hip or knee replacement: a
meta-analysis of the randomised trials. Lancet. 2001;358(9275):9-15,
http://dx.doi.org/10.1016/S0140-6736(00)05249-1.
18. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein
thrombosis in the general population: systematic review. Eur J Vasc
Endovasc Surg. 2003;25(1):1-5, http://dx.doi.org/10.1053/ejvs.2002.1778.
19. Bhandari M, Morrow F, Kulkarni AV, Tornetta P3rd. Meta-analyses in
orthopaedic surgery. A systematic review of their methodologies. J Bone
Joint Surg Am. 2001;83A(1):15-24.
20. Gross M, Anderson DR, Nagpal S, O’Brien B. Venous thromboembolism
prophylaxis after total hip or knee arthroplasty: a survey of Canadian
orthopedic surgeons. Can J Surg. 1999;42(6):457-61.
21. McNally MA, Mollan RA. Venous thromboembolism and orthopaedic
surgery. J Bone Joint Surg Br. 1993;75(4):517-9.
22. Prentice CR. Thromboprophylaxis in elective orthopaedic surgery—what
is the purpose? J Bone Joint Surg Br. 1997;79(6):889-90, http://dx.doi.org/
10.1302/0301-620X.79B6.8449.
23. Sarmiento A, Goswami AD. Thromboembolic prophylaxis with use of
aspirin, exercise, and graded elastic stockings or intermittent compres-
sion devices in patients managed with total hip arthroplasty. J Bone Joint
Surg Am. 1999;81(30:339-46.
24. Goldberg A. Prevention of deep-vein thrombosis after total knee
replacement. J Bone Joint Surg Br. 2000;82(2):304-5.
25. Lotke PA, Ecker ML, Alavi A, Berkowitz H. Indications for the treatment
of deep venous thrombosis following total knee replacement. J Bone Joint
Surg Am. 1984;66(2):202-8.
26. Gillespie W, Murray D, Gregg PJ, Warwick D. Risks and benefits of
prophylaxis against venous thromboembolism in orthopaedic surgery.
J Bone Joint Surg Br. 2000;82(4):475-9, http://dx.doi.org/10.1302/0301-
620X.82B4.10452.
27. Hirsh J. Prevention of venous thrombosis in patients undergoing major
orthopaedic surgical procedures. Acta Chir Scand. 1990(Suppl);556:30-5.
28. Wang CJ, Wang JW, Chen LM, Chen HS, Yang BY, Cheng SM. Deep vein
thrombosis after total knee arthroplasty. J Formos Med Assoc.
2000;99(11):848-53.
29. Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS,
Paiement G, et al. Comparison of ximelagatran with warfarin for the
prevention of venous thromboembolism after total knee replacement.
N Engl J Med. 2003;349(18):1703-12, http://dx.doi.org/10.1056/
NEJMoa035162.
30. Nathan S, Aleem MA, Thiagarajan P, Das De S. The incidence of
proximal deep vein thrombosis following total knee arthroplasty in an
Asian population: a Doppler ultrasound study. J Orthop Surg (Hong
Kong). 2003;11(2):184-9.
31. Sudo A, Sano T, Horikawa K, Yamakawa T, Shi D, Uchida A. The
incidence of deep vein thrombosis after hip and knee arthroplasties in
Japanese patients: a prospective study. J Orthop Surg (Hong Kong).
2003;11(2):174-7.
32. Della Valle CJ, Steiger DJ, Di Cesare PE. Thromboembolism after hip and
knee arthroplasty: diagnosis and treatment. J Am Acad Orthop Surg.
1998;6(6):327-36.
33. Khaw FM, Moran CG, Pinder IM, Smith SR. The incidence of fatal
pulmonary embolism after knee replacement with no prophylactic
anticoagulation. J Bone Joint Surg Br. 1993;75(6):940-1.
34. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL.
Frequency of myocardial infarction, pulmonary embolism, deep venous
thrombosis, and death following primary hip or knee arthroplasty.
Anesthesiology. 2002;96(5):1140-6.
35. Mitchell D, Friedman RJ, Baker JD3rd, Cooke JE, Darcy MD, Miller
MC3rd. Prevention of thromboembolic disease following total knee
arthroplasty. Epidural versus general anesthesia. Clin Orthop Relat Res.
1991(269):109-12.
36. Leclerc JR, Geerts WH, Desjardins L, Laflamme GH, L’Esperance B,
Demers C, et al. Prevention of venous thromboembolism after knee
arthroplasty. A randomized, double-blind trial comparing enoxaparin
with warfarin. Ann Intern Med. 1996;124(7):619-26.
37. Nielsen PT, Jorgensen LN, Albrecht-Beste E, Leffers AM, Rasmussen LS.
Lower thrombosis risk with epidural blockade in knee arthroplasty. Acta
Orthop Scand. 1990;61(1):29-31.
38. Sharrock NE, Haas SB, Hargett MJ, Urquhart B, Insall JN, Scuderi G.
Effects of epidural anesthesia on the incidence of deep-vein thrombosis
after total knee arthroplasty. J Bone Joint Surg Am. 1991;73(6):502-6.
39. Sharrock NE, Go G, Williams-Russo P, Haas SB, Harpel PC. Comparison
of extradural and general anaesthesia on the fibrinolytic response to total
knee arthroplasty. Br J Anaesth. 1997;79(1):29-34, http://dx.doi.org/
10.1093/bja/79.1.29.
40. Hollmann MW, Wieczorek KS, Smart M, Durieux ME. Epidural
anesthesia prevents hypercoagulation in patients undergoing major
orthopedic surgery. Reg Anesth Pain Med. 2001;26(3):215-22.
41. Macfarlane AJ, Prasad GA, Chan VW, Brull R. Does regional anesthesia
improve outcome after total knee arthroplasty? Clin Orthop Relat Res.
2009;467(9):2379-402, http://dx.doi.org/10.1007/s11999-008-0666-9.
42. Wilson JS, Miranda A, Johnson BL, Shames ML, Back MR, Bandyk DF.
Vascular injuries associated with elective orthopedic procedures. Ann
Vasc Surg. 2003;17(6):641-4, http://dx.doi.org/10.1007/s10016-003-0074-2.
43. Wauke K, Nagashima M, Kato N, Ogawa R, Yoshino S. Comparative
study between thromboembolism and total knee arthroplasty with or
without tourniquet in rheumatoid arthritis patients. Arch Orthop
Trauma Surg. 2002;122(8):442-6.
44. Wakankar HM, Nicholl JE, Koka R, D’Arcy JC. The tourniquet in total
knee arthroplasty. A prospective, randomised study. J Bone Joint Surg
Br. 1999;81(1):30-3, http://dx.doi.org/10.1302/0301-620X.81B1.8971.
45. Schuh A, Hausel M, Salminen S. [Effect of tourniquet use on blood loss in
total knee arthroplasty]. Zentralbl Chir. 2003;128(10):866-70.
46. Christodoulou AG, Ploumis AL, Terzidis IP, Chantzidis P, Metsovitis SR,
Nikiforos DG. The role of timing of tourniquet release and cementing on
perioperative blood loss in total knee replacement. Knee. 2004;11(4):313-
7, http://dx.doi.org/10.1016/j.knee.2003.09.005.
47. Aglietti P, Baldini A, Vena LM, Abbate R, Fedi S, Falciani M. Effect of
tourniquet use on activation of coagulation in total knee replacement.
Clin Orthop Relat Res. 2000(371):169-77.
48. Abdel-Salam A, Eyres KS. Effects of tourniquet during total knee
arthroplasty. A prospective randomised study. J Bone Joint Surg Br.
1995;77(2):250-3.
49. Portney L, Watkins M. Foundations of clinical research. 3rd ed. N:
Pearson Prentice Hall; 2009.p.277-300
50. Markovic-Deni L, Zivkovic K, Lesic A, et al. Risk factors and distribution
of symptomatic venous thromboembolism in total hip and knee
replacements: prospective study. Int Orthop. 2012;36(6):1299-305,
http://dx.doi.org/10.1007/s00264-011-1466-5.
CLINICS 2012;67(9):1053-1057 Tourniquet, Surgery Duration, and DVT in TKA
Hernandez AJ et al.
1057
